Bioequivalence Study of Patches With Different Release Profiles
Completed
- Conditions
- Female Contraception
- First Posted Date
- 2008-06-13
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 43
- Registration Number
- NCT00697307
A Study Evaluating Epoetin Alfa 40,000 IU (International Units) Every Week or 80,000 IU Every Week Compared to Placebo in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes at Risk for Transfusion
Phase 3
Terminated
- Conditions
- Myelodysplastic SyndromesAnemia
- Interventions
- Drug: Placebo
- First Posted Date
- 2008-06-11
- Last Posted Date
- 2012-10-05
- Target Recruit Count
- 25
- Registration Number
- NCT00695396
A Research Study to Evaluate the Safety of R306465, a Drug in Development for Cancer and to Study the Absorption, Break Down and Elimination in Patients With Advanced Solid Malignancies.
Phase 1
Completed
- Conditions
- Neoplasms
- First Posted Date
- 2008-05-13
- Last Posted Date
- 2010-04-27
- Target Recruit Count
- 15
- Registration Number
- NCT00677001
A Safety and Dose-finding Study of JNJ-26483327, a Drug in Development for Cancer, for Patients With Advanced and/or Refractory Solid Malignancies.
Phase 1
Completed
- Conditions
- Protein Kinase InhibitorsAntineoplastic ProtocolsClinical Trial, Phase 1Maximum Tolerated DosePharmacokineticsAdvanced MalignanciesSolid Malignancies
- First Posted Date
- 2008-05-13
- Last Posted Date
- 2010-04-26
- Target Recruit Count
- 19
- Registration Number
- NCT00676299
A Research Study of JNJ-26854165 to Determine the Safety and Dose in Patients With Advanced Stage or Refractory Solid Tumors.
Phase 1
Completed
- Conditions
- Neoplasms
- First Posted Date
- 2008-05-13
- Last Posted Date
- 2010-03-26
- Target Recruit Count
- 71
- Registration Number
- NCT00676910
A Safety and Dose-finding Study of JNJ-26481585 for Patients With Advanced Solid Malignancies and Lymphoma.
Phase 1
Completed
- Conditions
- LymphomaNeoplasms
- First Posted Date
- 2008-05-13
- Last Posted Date
- 2012-09-17
- Target Recruit Count
- 92
- Registration Number
- NCT00677105
A Study of the Enzyme Activity and Safety of Pancrelipase in Patients With Severe Exocrine Pancreatic Insufficiency (EPI)
Phase 1
Completed
- Conditions
- Exocrine Pancreatic InsufficiencyPancreatitis, ChronicSteatorrheaPancreatitis
- Interventions
- Dietary Supplement: Ensure Plus
- First Posted Date
- 2008-05-13
- Last Posted Date
- 2011-05-19
- Target Recruit Count
- 13
- Registration Number
- NCT00676702
A Study of the Histone-deacetylase Inhibitor JNJ-26481585 in Patients With Advanced or Refractory Leukemia or Myelodysplastic Syndrome
Phase 1
Terminated
- Conditions
- Advanced or Refractory LeukemiaMyelodysplastic Syndromes
- Interventions
- First Posted Date
- 2008-05-13
- Last Posted Date
- 2012-09-14
- Target Recruit Count
- 10
- Registration Number
- NCT00676728
A Study of the Safety and Effectiveness of a R256918 in Patients With Type 2 Diabetes
Phase 2
Completed
- Conditions
- Diabetes MellitusEndocrine System DiseasesNutritional and Metabolic DiseasesDiabetes Mellitus, Type 2
- Interventions
- First Posted Date
- 2008-05-06
- Last Posted Date
- 2014-07-14
- Target Recruit Count
- 352
- Registration Number
- NCT00672386
A 52 Week Open-label Extension Trial Following the Double-blind Efficacy and Safety Study R076477-SCH-305.
Phase 3
Completed
- Conditions
- Schizophrenia
- First Posted Date
- 2008-04-29
- Last Posted Date
- 2011-06-08
- Target Recruit Count
- 407
- Registration Number
- NCT00668837
© Copyright 2025. All Rights Reserved by MedPath